This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehmann, G. L.
Right arrow Articles by Bachenheimer, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehmann, G. L.
Right arrow Articles by Bachenheimer, S. L.

 Previous Article  |  Next Article 

Journal of Virology, August 2001, p. 7149-7160, Vol. 75, No. 15
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.15.7149-7160.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Pocket Protein p130/Rb2 Is Required for Efficient Herpes Simplex Virus Type 1 Gene Expression and Viral Replication

Ginger L. Ehmann,1 Heather A. Burnett,2 and Steven L. Bachenheimer1,2,3,*

Curriculum in Genetics and Molecular Biology,1 Department of Microbiology and Immunology,2 and Lineberger Comprehensive Cancer Center,3 University of North Carolina, Chapel Hill, North Carolina 27599-7290

Received 1 February 2001/Accepted 7 May 2001

We have reported previously that herpes simplex virus type 1 (HSV-1) infection disrupts normal progression of the mammalian cell cycle, causing cells to enter a G1-like state. Infected cells were characterized by a decline in cyclin-dependent kinase 2 (CDK2) activities, loss of hyperphosphorylated retinoblastoma protein (pRb), accumulation of E2F-pocket protein complexes, and failure to initiate cellular DNA replication. In the present study, we investigated the role of the pocket proteins pRb, p107, and p130 in HSV-1-dependent cell cycle inhibition and cyclin kinase regulation by infecting murine 3T3 cells derived from wild-type (WT) mouse embryos or embryos with deletions of pRb (pRb-/-), p107 (p107-/-), p130 (p130-/-), or both p130 and p107 (p130-/-/p107-/-). With respect to CDK2 inhibition, viral protein accumulation, viral DNA replication, and progeny virus yield, WT, pRb-/-, and p107-/- cells were essentially identical. In contrast, after infection of p130-/- cells, we observed no inhibition of CDK2 activity, a 5- to 6-h delay in accumulation of viral proteins, an impaired ability to form viral DNA replication compartments, and reduced viral DNA synthesis. As a result, progeny virus yield was reduced 2 logs compared to that in WT cells. Notably, p130-/-/p107-/- double-knockout cells had a virus replication phenotype intermediate between those of the p107-/- and p130-/- cells. We conclude from these studies that p130 is a key factor in regulating aspects of cell cycle progression, as well as the timely expression of viral genes and replication of viral DNA.


* Corresponding author. Mailing address: Department of Microbiology and Immunology, University of North Carolina, 837 Jones, CB#7290, Chapel Hill, NC 27599-7290. Phone: (919) 966-2445. Fax: (919) 962-8103. E-mail: bachlab{at}med.unc.edu.


Journal of Virology, August 2001, p. 7149-7160, Vol. 75, No. 15
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.15.7149-7160.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Leisenfelder, S. A., Moffat, J. F. (2006). Varicella-zoster virus infection of human foreskin fibroblast cells results in atypical cyclin expression and cyclin-dependent kinase activity.. J. Virol. 80: 5577-5587 [Abstract] [Full Text]  
  • Geiser, V., Jones, C. (2003). Stimulation of bovine herpesvirus-1 productive infection by the adenovirus E1A gene and a cell cycle regulatory gene, E2F-4. J. Gen. Virol. 84: 929-938 [Abstract] [Full Text]  
  • Schang, L. M. (2002). Cyclin-dependent kinases as cellular targets for antiviral drugs. J Antimicrob Chemother 50: 779-792 [Abstract] [Full Text]